Kupffer cell release of platelet activating factor drives dose limiting toxicities of nucleic acid nanocarriers-Reference-Cited by-同舟云学术

Kupffer cell release of platelet activating factor drives dose limiting toxicities of nucleic acid nanocarriers

Published:2021-01 Issue: Volume:268 Page:120528
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Jackson Meredith A.,Patel Shrusti S.,Yu Fang,Cottam Matthew A.,Glass Evan B.,Hoogenboezem Ella N.,Fletcher R. Brock,Dollinger Bryan R.,Patil Prarthana,Liu Danielle D.,Kelly Isom B.,Bedingfield Sean K.,King Allyson R.,Miles Rachel E.,Hasty Alyssa M.,Giorgio Todd D.,Duvall Craig L.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference66 articles.

1. Setten R. L., Rossi J. J., Han Sp., The current state and future directions of RNAi-based therapeutics, LID -, doi:10.1038/s41573-019-0017-4.

2. Update on the clinical utility of an RNA interference-based treatment: focus on Patisiran;Rizk;Pharmacogenomics Personalized Med.,2017

3. Polyplex evolution: understanding biology, optimizing performance;Hall;Mol. Ther.,2017

4. Unintended effects of drug carriers: big issues of small particles;Parhiz;Adv. Drug Deliv. Rev.,2018

5. In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine-graft-poly(ethylene glycol) block copolymers;Merkel;Biomaterials,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Covalent Polymer‐RNA Conjugates for Potent Activation of the RIG‐I Pathway;Advanced Healthcare Materials;2024-05-03

2. Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy;Nature Communications;2024-02-21

3. Lipid oxidation dysregulation: an emerging player in the pathophysiology of sepsis;Frontiers in Immunology;2023-08-03

4. Polyplex designs for improving the stability and safety of RNA therapeutics;Advanced Drug Delivery Reviews;2023-08

5. Core polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencing;Biomaterials;2023-06